Tsamakis, K;
Mueller, C;
Hortis, I;
Kallergi, M;
Tolos, I;
Alevyzakis, E;
Siafakas, N;
Ouranidis, A;
Tsiptsios, D;
Kympouropoulos, S;
et al.
Tsamakis, K; Mueller, C; Hortis, I; Kallergi, M; Tolos, I; Alevyzakis, E; Siafakas, N; Ouranidis, A; Tsiptsios, D; Kympouropoulos, S; Spandidos, DA; Smyrnis, N; Rizos, E
(2021)
Association of antipsychotic use with raised eosinophil count.
Exp Ther Med, 21 (5).
p. 513.
ISSN 1792-0981
https://doi.org/10.3892/etm.2021.9944
SGUL Authors: Tsamakis, Konstantinos
Abstract
The current study aimed to assess the possibility of an association between first and second generation antipsychotic medication and raised eosinophil count. A total of 22 in-patients at the psychiatric unit of the University General Hospital 'Attikon', a tertiary hospital, were included in the present study. Patients had received antipsychotic monotherapy and did not have any co-morbidities or require additional treatments. Patients were monitored weekly and their eosinophil count was assessed. One-way ANOVA and summary measures analysis were applied to study the effect of time and medication type on the absolute eosinophil concentration (or relative percentage) for each patient. The differences in mean eosinophil concentrations or relative percentage by patient and time were also assessed. An increase in the absolute concentration and the relative percentage of eosinophils over time was observed in patients receiving Olanzapine, Haloperidol and Aripiprazole. However, there was no difference between individual medications. In conclusion, antipsychotics may be associated with increased eosinophil count over time; however, larger studies involving more patients and a longer follow-up are required to reach a definitive conclusion.
Item Type: |
Article
|
Additional Information: |
© Tsamakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc-nd/4.0/).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. |
Keywords: |
antipsychotics, aripiprazole, eosinophil count, first and second generation, haloperidol, monotherapy, olanzapine, antipsychotics, eosinophil count, monotherapy, first and second generation, olanzapine, haloperidol, aripiprazole |
SGUL Research Institute / Research Centre: |
Academic Structure > Institute of Medical & Biomedical Education (IMBE) |
Journal or Publication Title: |
Exp Ther Med |
ISSN: |
1792-0981 |
Language: |
eng |
Dates: |
Date | Event |
---|
May 2021 | Published | 19 March 2021 | Published Online | 26 January 2021 | Accepted |
|
Publisher License: |
Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 |
PubMed ID: |
33791022 |
Web of Science ID: |
WOS:000635072500001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/113395 |
Publisher's version: |
https://doi.org/10.3892/etm.2021.9944 |
Statistics
Item downloaded times since 07 Jul 2021.
Actions (login required)
|
Edit Item |